Fundz
Funding, M&A, exec moves and hiring — matched to your market, with the people to call.See plans →

Nasus Pharma Appoints Brendan P. O'grady As Chief Executive Officer

PUBLIC · NSRXJul 28, 2026•12 days ago

Position

Chief Executive Officer

Company

Nasus Pharma

Brendan P. O'Grady
Tel AvivBiotechnologyHealth CareTherapeuticsPharmaceutical

Description

Nasus Pharma Ltd. announces the appointment of Brendan P. O'Grady as its new Chief Executive Officer

Company Information

Company

Nasus Pharma

Location

Tel Aviv, Tel Aviv District, Israel

About

Nasus Pharma is a clinical-stage pharmaceutical company focused on the development of innovative intranasal products to treat emergency medical conditions. The company is advancing its pipeline of intranasal therapeutics towards achieving key clinical and commercial milestones.

Related People

Suggested for you

Choose your plan to reveal verified contacts

Choose your plan to reveal verified contacts

Predictive Intelligence
Strategic

ML-powered predictions for Nasus Pharma's next move

Learn about Strategic plan

Executive Insights

Based on hiring data
New executive impact window
87% of new executives make significant technology decisions within first 100 days
Budget influence
C-level executives control 73% of technology spending decisions
Transformation catalyst
65% of new senior hires launch digital transformation initiatives
Vendor review timeline
New executives typically review existing vendors within 6 months

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals — including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications — based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 200,000+ companies. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.